Uncoupling protein‐2 promotes nigrostriatal dopamine neuronal function

Uncoupling protein 2 (UCP2) is known to promote neuroprotection in many forms of neurological pathologies including Parkinson's disease. Here, we examined the hypothesis that UCP2 also mediates aspects of normal nigrostriatal dopamine (DA) function. Mice lacking UCP2 exhibited reduced dopamine turnover in the striatum as measured by the 3,4‐dihydoxyphenylacetic acid/dopamine (DOPAC/DA) ratio, reduced tyrosine hydroxylase immunoreactivity (TH IR) in the substantia nigra pars compacta (SNc) and reticulata, striatum and nucleus accumbens. UCP2‐knockout (KO) mice also had reduced dopamine transporter immunoreactivity (DAT IR) in the SNc but not other brain regions examined. In order to determine if these biochemical deficits are transcribed into behavioural deficits, we examined locomotor function in UCP2‐KO mice compared to wild‐type (WT) controls. UCP2‐KO mice exhibited significantly reduced total movement distance, movement velocity and increased rest time compared to wild‐type controls. These results suggest that UCP2 is an important mitochondrial protein that helps to maintain normal nigrostriatal dopamine neuronal function and a reduction in UCP2 levels may predispose individuals to environmental causes of Parkinson's disease.

[1]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[2]  Pamela Maher,et al.  Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6‐methyl‐phenyl‐tetrahydropyridine toxicity , 2005, Journal of neurochemistry.

[3]  Tamas L. Horvath,et al.  Uncoupling Protein-2 Is Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson's Disease , 2005, The Journal of Neuroscience.

[4]  R. Rizzuto,et al.  Mitochondrial calcium signalling in cell death , 2005, The FEBS journal.

[5]  Cheryl D. DiCarlo,et al.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone , 2004, Experimental Neurology.

[6]  M. Rice,et al.  Partial Mitochondrial Inhibition Causes Striatal Dopamine Release Suppression and Medium Spiny Neuron Depolarization via H2O2 Elevation, Not ATP Depletion , 2005, The Journal of Neuroscience.

[7]  T. Horvath,et al.  Mitochondrial uncoupling proteins in the cns: in support of function and survival , 2005, Nature Reviews Neuroscience.

[8]  P. Hollenbeck.  Mitochondria and Neurotransmission: Evacuating the Synapse , 2005, Neuron.

[9]  F Benfenati,et al.  Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects. , 1984, Acta physiologica Scandinavica. Supplementum.

[10]  S. Budd,et al.  Mitochondria and neuronal survival. , 2000, Physiological reviews.

[11]  K. Fuxe,et al.  Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: Relevance for volume transmission , 2006, Neuroscience.

[12]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[13]  C. Richter.  Do mitochondrial DNA fragments promote cancer and aging? , 1988, FEBS letters.

[14]  G. Tomasevic,et al.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.

[15]  J. Fike,et al.  Cell-density-dependent regulation of neural precursor cell function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Barnstable,et al.  Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. , 2003, Endocrinology.

[17]  J. Tepper,et al.  Endogenous Hydrogen Peroxide Regulates the Excitability of Midbrain Dopamine Neurons via ATP-Sensitive Potassium Channels , 2005, The Journal of Neuroscience.

[18]  B. Liss,et al.  ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[19]  Bertrand Friguet,et al.  Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease , 2003, Journal of neurochemistry.

[20]  T. Di Paolo,et al.  Dopamine Transporter as a Marker of Neuroprotection in Methamphetamine-Lesioned Mice Treated Acutely with Estradiol , 2004, Neuroendocrinology.

[21]  T. Di Paolo,et al.  Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice , 2005, Journal of neuroendocrinology.

[22]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[23]  Jochen Roeper,et al.  K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons , 2005, Nature Neuroscience.

[24]  L. F. Agnati,et al.  Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2 , 2004, Journal of Neural Transmission.

[25]  O. Steward,et al.  Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death , 2003, Annals of neurology.

[26]  Yasunori Hayashi,et al.  The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses , 2004, Cell.